Application of novel CAR technologies to improve treatment of autoimmune disease.

Front Immunol · 2024 · PMC11496059 · PMID 39445021

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

However, autoantigens often have other natural binding partners in the body, not just the autoreactive BCRs, and if the CAAR binds to other cells or soluble proteins in the body, there may be significant side effects.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.